Health Care
JNJ · Johnson & Johnson
$271.22 Close · 2026-09-25
Close50-day avg200-day avg
Short-term view (1–4 weeks)
BuyRank #21 of 8570
+ Strengths
- + strong 1-month price momentum
- + RSI in the healthy 50–70 momentum zone
- + outperforming the S&P 500 this month
− Risks
- − move lacks volume support
Entry, stop and target levels plus the full factor breakdown are free with an account.Join free
Long-term view (6–24 months)
BuyRank #2 of 8573
+ Strengths
- + persistent 12-month uptrend
- + excellent return per unit of risk
- + above its long-term 200-day trend
− Risks
- No standout weaknesses
Entry, stop and target levels plus the full factor breakdown are free with an account.Join free
Fundamentals
- Market cap
- $653.6B
- P/E (TTM)
- 31.1
- Return on equity
- 25.7%
- Revenue growth (YoY)
- +8.1%
- Net margin
- 21.5%
- Debt / equity
- 0.58
- Dividend yield
- 1.93%
- Beta
- 0.21
- 52-week high
- $281.07
- 52-week low
- $175.91
Latest news
Company news is included with a free account.
Model output for education and research — not financial advice or a personal recommendation. Always do your own research and manage your risk.